Cargando…

Pushing the Limits of Cancer Therapy: The Nutrient Game

The standard cancer treatments include chemotherapy, radiotherapy, or their combination, which are generally associated with a multitude of side effects ranging from discomfort to the development of secondary tumors and severe toxicity to multiple systems including immune system. Mounting evidence h...

Descripción completa

Detalles Bibliográficos
Autores principales: Lettieri-Barbato, Daniele, Aquilano, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951973/
https://www.ncbi.nlm.nih.gov/pubmed/29868472
http://dx.doi.org/10.3389/fonc.2018.00148
_version_ 1783323109750734848
author Lettieri-Barbato, Daniele
Aquilano, Katia
author_facet Lettieri-Barbato, Daniele
Aquilano, Katia
author_sort Lettieri-Barbato, Daniele
collection PubMed
description The standard cancer treatments include chemotherapy, radiotherapy, or their combination, which are generally associated with a multitude of side effects ranging from discomfort to the development of secondary tumors and severe toxicity to multiple systems including immune system. Mounting evidence has highlighted that the fine-tuning of nutrients may selectively sensitize cancer cells to conventional cancer therapies, while simultaneously protecting normal cells from their side effects. Nutrient modulation through diet also improves cancer immunesurveillance in a way that severe immunosuppression could be avoided or even the immune response or immune-based cancer therapies be potentiated also through patient microbiota remodeling. Here, we review recent advances in cancer therapy focusing on the effects of adjuvant dietary interventions (e.g., ketogenic diets, fasting) on the metabolic pathways within cancer cells and tumor environment (e.g., microbiota, immune system, tumor microenvironment) that are involved in cancer progression and resistance as well as cancer cell death. Finally, based on the overall literature data, we designed a nutritional intervention consisting in a plant-based moderate ketogenic diet that could be exploited for future preclinical research in cancer therapy.
format Online
Article
Text
id pubmed-5951973
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59519732018-06-04 Pushing the Limits of Cancer Therapy: The Nutrient Game Lettieri-Barbato, Daniele Aquilano, Katia Front Oncol Oncology The standard cancer treatments include chemotherapy, radiotherapy, or their combination, which are generally associated with a multitude of side effects ranging from discomfort to the development of secondary tumors and severe toxicity to multiple systems including immune system. Mounting evidence has highlighted that the fine-tuning of nutrients may selectively sensitize cancer cells to conventional cancer therapies, while simultaneously protecting normal cells from their side effects. Nutrient modulation through diet also improves cancer immunesurveillance in a way that severe immunosuppression could be avoided or even the immune response or immune-based cancer therapies be potentiated also through patient microbiota remodeling. Here, we review recent advances in cancer therapy focusing on the effects of adjuvant dietary interventions (e.g., ketogenic diets, fasting) on the metabolic pathways within cancer cells and tumor environment (e.g., microbiota, immune system, tumor microenvironment) that are involved in cancer progression and resistance as well as cancer cell death. Finally, based on the overall literature data, we designed a nutritional intervention consisting in a plant-based moderate ketogenic diet that could be exploited for future preclinical research in cancer therapy. Frontiers Media S.A. 2018-05-08 /pmc/articles/PMC5951973/ /pubmed/29868472 http://dx.doi.org/10.3389/fonc.2018.00148 Text en Copyright © 2018 Lettieri-Barbato and Aquilano. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Lettieri-Barbato, Daniele
Aquilano, Katia
Pushing the Limits of Cancer Therapy: The Nutrient Game
title Pushing the Limits of Cancer Therapy: The Nutrient Game
title_full Pushing the Limits of Cancer Therapy: The Nutrient Game
title_fullStr Pushing the Limits of Cancer Therapy: The Nutrient Game
title_full_unstemmed Pushing the Limits of Cancer Therapy: The Nutrient Game
title_short Pushing the Limits of Cancer Therapy: The Nutrient Game
title_sort pushing the limits of cancer therapy: the nutrient game
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951973/
https://www.ncbi.nlm.nih.gov/pubmed/29868472
http://dx.doi.org/10.3389/fonc.2018.00148
work_keys_str_mv AT lettieribarbatodaniele pushingthelimitsofcancertherapythenutrientgame
AT aquilanokatia pushingthelimitsofcancertherapythenutrientgame